Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
(±)-ML 209 is a novel and selective RORγ antagonist, which suppresses human TH17 cell differentiation at submicromolar concentrations. (±)-ML 209 has potential to treat TH17-related autoimmune diseases.
您的位置：
